Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 23155-170

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 23155-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 01

F8f249ce 41d0 4cff 8185 0fd2ed393361 01
Chemical structure of zoledronic acid, showing a heterocyclic imidazole ring and two phosphonic acid groups along with associated hydroxyl and water moieties.*
FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 02

F8f249ce 41d0 4cff 8185 0fd2ed393361 02
A formula calculation for creatinine clearance (CrCl) that considers age, weight, and serum creatinine, with an adjustment factor of 0.85 for female patients. The formula is displayed as CrCl = [140 - age (years)] × weight (kg) × 0.85 for females, divided by [72 × serum creatinine (mg/dL)].*
FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 03

F8f249ce 41d0 4cff 8185 0fd2ed393361 03
A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' compares Zoledronic acid injection 4 mg with Pamidronate 90 mg. The vertical axis shows percentage of complete responders from 0% to 100%. Zoledronic acid demonstrates a higher response rate than Pamidronate, with a statistical significance indicated (P=0.002).*
FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 04

FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 05

F8f249ce 41d0 4cff 8185 0fd2ed393361 05
Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion in a 5 mL sterile single-dose vial. The label includes usage warnings such as not for direct injection and dosage must be diluted. It lists the manufacturer as Emcure Pharmaceuticals Ltd. and labeler as Avet Pharmaceuticals Inc. Includes storage instructions and barcode.*
FDA Label Image

F8f249ce 41d0 4cff 8185 0fd2ed393361 06

F8f249ce 41d0 4cff 8185 0fd2ed393361 06
Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion. The label states it is a sterile single-dose vial not for direct injection and must be diluted. Manufactured by Emcure Pharmaceuticals Ltd., labeled for Avet Pharma (Heritage Pharmaceuticals Inc.). Includes storage and handling instructions, NDC 23155-170-31, and batch detail areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.